Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01578486 · ClinicalTrials.gov registry record · Phase 4
Salsalate as an Adjunctive Treatment for Patients With Schizophrenia
A Phase 4 study, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- Phase 4
- Development phase
- 17
- Enrollment target
NCT01578486 is a Phase 4 study that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 17 participants.
The verdict
NCT01578486, a Phase 4 study, has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 17 participants
- Enrollment target
Study Summary
This is a 12-week, open-label trial of salsalate 3 g/day as an adjunctive treatment in 15 schizophrenia subjects to examine salsalate's effect on psychopathology, cognitive functioning, and metabolic parameters. Potential subjects will be identified by their clinicians at the Freedom Trail Clinic, or Massachusetts General Hospital. A total of 15 subjects will be enrolled.
Interventions
- DRUG salsalate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2011-06 |
| Est. Completion | 2015-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01578486
The ClinicalTrials.gov registry entry for NCT01578486 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which salsalate is the first listed.
NCT01578486 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01578486 about?
NCT01578486 is a clinical study titled "Salsalate as an Adjunctive Treatment for Patients With Schizophrenia". This is a 12-week, open-label trial of salsalate 3 g/day as an adjunctive treatment in 15 schizophrenia subjects to examine salsalate's effect on psychopathology, cognitive functioning, and metabolic parameters. Potential subjects will be identified by their clinicians at the Freedom Trail Clinic, ...
What is the current status of trial NCT01578486?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 17 participants. The study started on 2011-06. Estimated completion is 2015-07.
What interventions are being tested in trial NCT01578486?
The interventions under investigation include: salsalate (DRUG).
Who is sponsoring clinical trial NCT01578486?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.